Go Pro

MarketBeat Instant News Alerts

AllianceBernstein Global High Income Fund logo with Finance background

AllianceBernstein Global High Income Fund, Inc. (NYSE:AWF) Plans $0.07 Monthly Dividend

AllianceBernstein Global High Income Fund, Inc. (NYSE:AWF) declared a monthly dividend on Monday, September 21st. Stockholders of record on Thursday, October 1st will be given a dividend of 0.0655 per share by the closed-end fund on Friday, October 16th. This represents a c) annualized dividend and a dividend yield of 7.9%. The ex-dividend date is Thursday, October 1st.

NYSE:AWF
Read AllianceBernstein Global High Income Fund, Inc. (NYSE:AWF) Plans $0.07 Monthly Dividend
Xenia Hotels & Resorts logo with Real Estate background

Xenia Hotels & Resorts, Inc. (NYSE:XHR) to Issue $0.14 Quarterly Dividend

Xenia Hotels & Resorts, Inc. (NYSE:XHR) declared a quarterly dividend on Monday, September 21st. Investors of record on Wednesday, September 30th will be paid a dividend of 0.14 per share by the real estate investment trust on Thursday, October 15th. This represents a c) annualized dividend and a dividend yield of 3.1%. The ex-dividend date is Wednesday, September 30th.

NYSE:XHR
Read Xenia Hotels & Resorts, Inc. (NYSE:XHR) to Issue $0.14 Quarterly Dividend
Travere Therapeutics logo with Healthcare background

Travere Therapeutics' (TVTX) "Outperform" Rating Reaffirmed at Wedbush

Wedbush reiterated an "outperform" rating and issued a $76.00 price objective on shares of Travere Therapeutics in a report on Tuesday.

NASDAQ:TVTX
Read Travere Therapeutics' (TVTX) "Outperform" Rating Reaffirmed at Wedbush
Nextpower logo with Industrials background

Nextpower (NASDAQ:NXT) Price Target Lowered to $116.00 at Robert W. Baird

Robert W. Baird decreased their target price on Nextpower from $156.00 to $116.00 and set an "outperform" rating for the company in a research note on Tuesday.

NASDAQ:NXT
Read Nextpower (NASDAQ:NXT) Price Target Lowered to $116.00 at Robert W. Baird
Meta Platforms logo with Communication Services background

Jefferies Financial Group Raises Meta Platforms (NASDAQ:META) Price Target to $875.00

Jefferies Financial Group lifted their target price on Meta Platforms from $710.00 to $875.00 and gave the stock a "buy" rating in a research report on Tuesday.

NASDAQ:META
Read Jefferies Financial Group Raises Meta Platforms (NASDAQ:META) Price Target to $875.00
Ionis Pharmaceuticals logo with Healthcare background

JPMorgan Chase & Co. Issues Pessimistic Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price

JPMorgan Chase & Co. dropped their price objective on shares of Ionis Pharmaceuticals from $76.00 to $70.00 and set an "overweight" rating on the stock in a research note on Tuesday.

NASDAQ:IONS
Read JPMorgan Chase & Co. Issues Pessimistic Forecast for Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price

Trending News

All MarketBeat Instant News Alerts

Driven Brands logo with Consumer Discretionary background

Barclays Reaffirms "Equal Weight" Rating for Driven Brands (NASDAQ:DRVN)

NASDAQ:DRVN
Read Barclays Reaffirms "Equal Weight" Rating for Driven Brands (NASDAQ:DRVN)
Abivax logo with Healthcare background

Abivax (NASDAQ:ABVX) Given New $118.00 Price Target at Wedbush

NASDAQ:ABVX
Read Abivax (NASDAQ:ABVX) Given New $118.00 Price Target at Wedbush
Abivax logo with Healthcare background

Barclays Reaffirms Overweight Rating for Abivax (NASDAQ:ABVX)

NASDAQ:ABVX
Read Barclays Reaffirms Overweight Rating for Abivax (NASDAQ:ABVX)
Wabash National logo with Industrials background

Wabash National (NYSE:WNC) Given "Buy" Rating at DA Davidson

NYSE:WNC
Read Wabash National (NYSE:WNC) Given "Buy" Rating at DA Davidson
Constellation Brands logo with Consumer Staples background

Constellation Brands (NYSE:STZ) Price Target Lowered to $122.00 at Barclays

NYSE:STZ
Read Constellation Brands (NYSE:STZ) Price Target Lowered to $122.00 at Barclays
AutoZone logo with Consumer Discretionary background

AutoZone (NYSE:AZO) Announces Quarterly Earnings Results, Beats Expectations By $2.40 EPS

NYSE:AZO
Read AutoZone (NYSE:AZO) Announces Quarterly Earnings Results, Beats Expectations By $2.40 EPS
Heartflow logo with Healthcare background

Heartflow (NASDAQ:HTFL) Price Target Raised to $56.00 at Canaccord Genuity Group

NASDAQ:HTFL
Read Heartflow (NASDAQ:HTFL) Price Target Raised to $56.00 at Canaccord Genuity Group
Alkermes logo with Healthcare background

Alkermes (NASDAQ:ALKS) Price Target Raised to $61.00

NASDAQ:ALKS
Read Alkermes (NASDAQ:ALKS) Price Target Raised to $61.00
Valero Energy logo with Energy background

Valero Energy (NYSE:VLO) Given "Hold" Rating at Jefferies Financial Group

NYSE:VLO
Read Valero Energy (NYSE:VLO) Given "Hold" Rating at Jefferies Financial Group
GRAIL logo with Healthcare background

GRAIL (NASDAQ:GRAL) Stock Price Expected to Rise, Robert W. Baird Analyst Says

NASDAQ:GRAL
Read GRAIL (NASDAQ:GRAL) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Terrestrial Energy logo with Industrials background

Terrestrial Energy Inc. (NASDAQ:IMSR) Given Consensus Recommendation of "Hold" by Analysts

NASDAQ:IMSR
Read Terrestrial Energy Inc. (NASDAQ:IMSR) Given Consensus Recommendation of "Hold" by Analysts
Brinker International logo with Consumer Discretionary background

Brinker International (NYSE:EAT) Upgraded at Northcoast Research

NYSE:EAT
Read Brinker International (NYSE:EAT) Upgraded at Northcoast Research
Tiziana Life Sciences logo with Healthcare background

BTIG Research Reaffirms "Buy" Rating for Tiziana Life Sciences (NASDAQ:TLSA)

NASDAQ:TLSA
Read BTIG Research Reaffirms "Buy" Rating for Tiziana Life Sciences (NASDAQ:TLSA)
Atlanticus logo with Finance background

Atlanticus (NASDAQ:ATLC) Earns "Buy" Rating from BTIG Research

NASDAQ:ATLC
Read Atlanticus (NASDAQ:ATLC) Earns "Buy" Rating from BTIG Research
Upstart logo with Finance background

Upstart's (UPST) "Buy" Rating Reiterated at BTIG Research

NASDAQ:UPST
Read Upstart's (UPST) "Buy" Rating Reiterated at BTIG Research
Adaptive Biotechnologies logo with Healthcare background

Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research

NASDAQ:ADPT
Read Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research
PTC Therapeutics logo with Healthcare background

Cantor Fitzgerald Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $137.00

NASDAQ:PTCT
Read Cantor Fitzgerald Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $137.00
McGraw Hill logo with Consumer Discretionary background

BTIG Research Reiterates "Buy" Rating for McGraw Hill (NYSE:MH)

NYSE:MH
Read BTIG Research Reiterates "Buy" Rating for McGraw Hill (NYSE:MH)
Hyperfine logo with Healthcare background

BTIG Research Reiterates Buy Rating for Hyperfine (NASDAQ:HYPR)

NASDAQ:HYPR
Read BTIG Research Reiterates Buy Rating for Hyperfine (NASDAQ:HYPR)
Tyra Biosciences logo with Healthcare background

Tyra Biosciences (NASDAQ:TYRA) Price Target Lowered to $29.00 at HC Wainwright

NASDAQ:TYRA
Read Tyra Biosciences (NASDAQ:TYRA) Price Target Lowered to $29.00 at HC Wainwright
Eldorado Gold logo with Materials background

Eldorado Gold (NYSE:EGO) Stock Rating Upgraded by Bank of America

NYSE:EGO
Read Eldorado Gold (NYSE:EGO) Stock Rating Upgraded by Bank of America
Travere Therapeutics logo with Healthcare background

Travere Therapeutics' (TVTX) Buy Rating Reaffirmed at HC Wainwright

NASDAQ:TVTX
Read Travere Therapeutics' (TVTX) Buy Rating Reaffirmed at HC Wainwright
Vista Gold logo with Materials background

Vista Gold (NYSEAMERICAN:VGZ) Given Buy Rating at HC Wainwright

NYSEAMERICAN:VGZ
Read Vista Gold (NYSEAMERICAN:VGZ) Given Buy Rating at HC Wainwright
Kymera Therapeutics logo with Healthcare background

Stifel Nicolaus Forecasts Strong Price Appreciation for Kymera Therapeutics (NASDAQ:KYMR) Stock

NASDAQ:KYMR
Read Stifel Nicolaus Forecasts Strong Price Appreciation for Kymera Therapeutics (NASDAQ:KYMR) Stock

Featured Articles and Offers

Alert Categories

All Alerts